327 related articles for article (PubMed ID: 3807995)
41. Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix.
Waggoner SE; Anderson SM; Van Eyck S; Fuller J; Luce MC; Herbst AL
Obstet Gynecol; 1994 Sep; 84(3):404-8. PubMed ID: 8058239
[TBL] [Abstract][Full Text] [Related]
42. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma.
Waggoner SE; Mittendorf R; Biney N; Anderson D; Herbst AL
Gynecol Oncol; 1994 Nov; 55(2):238-44. PubMed ID: 7959291
[TBL] [Abstract][Full Text] [Related]
43. Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix.
Herbst AL; Cole P; Norusis MJ; Welch WR; Scully RE
Am J Obstet Gynecol; 1979 Dec; 135(7):876-86. PubMed ID: 507130
[TBL] [Abstract][Full Text] [Related]
44. [Teratogenic effect of diethylstilbestrol during pregnancy; the extent of the DES problem in the Netherlands].
Stolk JG; Vooijs GP; Aartsen EJ; Heintz AP
Ned Tijdschr Geneeskd; 1982 Jul; 126(30):1350-8. PubMed ID: 7133167
[No Abstract] [Full Text] [Related]
45. Physical and psychological effects of DES on exposed offspring.
Konicki AM
Cancer Nurs; 1985 Aug; 8(4):233-7. PubMed ID: 3850790
[No Abstract] [Full Text] [Related]
46. Treatment of clear cell adenocarcinoma in young females.
Wharton JT; Rutledge FN; Gallager HS; Fletcher G
Obstet Gynecol; 1975 Apr; 45(4):365-8. PubMed ID: 1121369
[TBL] [Abstract][Full Text] [Related]
47. Risk factors for diethylstilbestrol-associated clear cell adenocarcinoma.
Palmer JR; Anderson D; Helmrich SP; Herbst AL
Obstet Gynecol; 2000 Jun; 95(6 Pt 1):814-20. PubMed ID: 10831973
[TBL] [Abstract][Full Text] [Related]
48. Health risks and effects of prenatal exposure to diethylstilbestrol.
Johnston GA
J Fam Pract; 1983 Jan; 16(1):51-4. PubMed ID: 6848637
[TBL] [Abstract][Full Text] [Related]
49. Summary of the changes in the human female genital tract as a consequence of maternal diethylstilbestrol therapy.
Herbst AL
J Toxicol Environ Health Suppl; 1976; 1():13-20. PubMed ID: 994230
[TBL] [Abstract][Full Text] [Related]
50. Cervical and vaginal cancer detection at a regional diethylstilbestrol (DES) screening clinic.
Piver MS; Lele SB; Baker TR; Sandecki A
Cancer Detect Prev; 1988; 11(3-6):197-202. PubMed ID: 3390844
[TBL] [Abstract][Full Text] [Related]
51. Follow-up study of male and female offspring of DES-treated mothers a preliminary report.
Bibbo M; Al-Naqeeb M; Baccarini I; Gill W; Newton M; Sleeper KM; Sonek RN; Wied GL
J Reprod Med; 1975 Jul; 15(1):29-32. PubMed ID: 1171234
[TBL] [Abstract][Full Text] [Related]
52. Symposium on Adolescent Gynecology and Endocrinology. Part II: Secondary amenorrhea, hirsutism in adolescents and the clinical consequences of stilbestrol exposure in utero. The clinical consequences of stilbestrol exposure in utero.
Kurman RJ
West J Med; 1979 Dec; 131(6):526-32. PubMed ID: 545869
[TBL] [Abstract][Full Text] [Related]
53. In utero exposure to DES. Evaluation and followup of 199 women.
Fowler WC; Edelman DA
Obstet Gynecol; 1978 Apr; 51(4):459-63. PubMed ID: 662229
[TBL] [Abstract][Full Text] [Related]
54. DES daughters in France: experts' points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure.
Clement R; Guilbaud E; Barrios L; Rougé-Maillart C; Jousset N; Rodat O
Med Sci Law; 2014 Oct; 54(4):219-29. PubMed ID: 24534146
[TBL] [Abstract][Full Text] [Related]
55. Risk factors for the development of diethylstilbestrol-associated clear cell adenocarcinoma: a case-control study.
Herbst AL; Anderson S; Hubby MM; Haenszel WM; Kaufman RH; Noller KL
Am J Obstet Gynecol; 1986 Apr; 154(4):814-22. PubMed ID: 3963071
[TBL] [Abstract][Full Text] [Related]
56. Study of prenatal DES exposure and its consequences in Rochester, Minnesota.
Noller KL; Kurland LT
J Toxicol Environ Health Suppl; 1976; 1():1-11. PubMed ID: 994228
[TBL] [Abstract][Full Text] [Related]
57. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol.
Newbold RR; McLachlan JA
Cancer Res; 1982 May; 42(5):2003-11. PubMed ID: 7066910
[TBL] [Abstract][Full Text] [Related]
58. Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks.
Hanselaar A; van Loosbroek M; Schuurbiers O; Helmerhorst T; Bulten J; Bernhelm J
Cancer; 1997 Jun; 79(11):2229-36. PubMed ID: 9179071
[TBL] [Abstract][Full Text] [Related]
59. DES exposure and the aging woman: mothers and daughters.
Laitman CJ
Curr Womens Health Rep; 2002 Oct; 2(5):390-3. PubMed ID: 12215312
[TBL] [Abstract][Full Text] [Related]
60. DES-related clear cell adenocarcinoma of the vagina in pregnancy.
Jones WB; Woodruff JM; Erlandson RA; Lewis JL
Obstet Gynecol; 1981 Jun; 57(6 Suppl):76S-80S. PubMed ID: 7243130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
